Notes on Gene Therapy and Gene Editing Concepts

Chapter 1: Successful Gene Therapy

General Introduction to Gene Therapy

  • Gene therapy relies on the use of viruses to deliver therapeutic genes into the host's DNA.
  • Key Concerns:
    • The virus may integrate into the host's DNA, leading to unintended activation of oncogenes.
    • Risks associated with random insertion into host chromosomes.
  • Two primary types of viral vectors discussed:
    1. Empty Vectors:
    • Contain the minimal necessary components of the virus genome.
    • Reduced risk of inserting a therapeutic gene in random locations.
    1. Adeno-associated Viruses (AAV):
    • Designed to minimize the risk of oncogenesis and insertional mutagenesis.

Case Study: Successful Gene Therapy in Clinical Practice

  • The first clinically successful and commercially approved gene therapy:
    • FDA Approval Date: 2017
    • Target Condition: Spinal Muscular Atrophy (SMA)
    • Nature of SMA: Autosomal recessive disorder caused by mutations in the SMN1 gene, essential for motor neuron function.
    • Impacts on Patients: Significant motor deficiencies in babies as a result of lack of SMN protein production.

Treatment Outcomes

  • Treatment Method:
    • Utilization of a specific gene therapy to restore function in SMA patients.
    • Visual representation (refer to slide) illustrating the differences before and after treatment.
  • Results:
    • The baseline condition of patients involves constant blistering, which signifies declining motor function and health.
    • After three months of treatment, significant improvement in the overall condition of the patient is observed.

Introduction to Gene Editing

  • Gene editing is a novel technology gaining prominence in the field.
  • Methodology:
    • Involves the use of guide molecules to alter specific parts of DNA.
    • Recommendations for specific gene targeting to skip mutations (e.g., skip a deletion).
  • Implications of this technology on genetic disorders.

Chapter 2: A Great Deletion

  • Description of a significant genetic deletion affecting cellular function.
  • While details are sparse, the discussion revolves around:
    • The implications of large deletions on gene expression.
    • Potential consequences for cellular mechanisms or phenotypic outcomes.

Summary

  • Gene therapy and gene editing technologies represent significant advancements in treating genetic disorders.
  • Focus on reducing risks associated with traditional gene delivery methods while emphasizing the need for greater precision in genetic alterations.